Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1975 1
1976 2
1977 2
1978 1
1979 2
1980 6
1981 10
1982 5
1983 6
1984 3
1985 1
1986 6
1987 4
1988 4
1989 2
1990 3
1991 3
1992 5
1993 5
1994 3
1995 4
1996 3
1997 3
1998 1
1999 4
2000 2
2001 2
2002 3
2003 11
2004 8
2005 9
2006 11
2007 6
2008 8
2009 16
2010 15
2011 17
2012 21
2013 21
2014 16
2015 14
2016 12
2017 8
2018 6
2019 9
2020 9
2021 7
2022 7
2023 4
2024 2
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

298 results

Results by year

Filters applied: . Clear all
Page 1
Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis.
Taylor PC, Keystone EC, van der Heijde D, Weinblatt ME, Del Carmen Morales L, Reyes Gonzaga J, Yakushin S, Ishii T, Emoto K, Beattie S, Arora V, Gaich C, Rooney T, Schlichting D, Macias WL, de Bono S, Tanaka Y. Taylor PC, et al. Among authors: keystone ec. N Engl J Med. 2017 Feb 16;376(7):652-662. doi: 10.1056/NEJMoa1608345. N Engl J Med. 2017. PMID: 28199814 Free article. Clinical Trial.
Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks.
Cohen SB, Emery P, Greenwald MW, Dougados M, Furie RA, Genovese MC, Keystone EC, Loveless JE, Burmester GR, Cravets MW, Hessey EW, Shaw T, Totoritis MC; REFLEX Trial Group. Cohen SB, et al. Among authors: keystone ec. Arthritis Rheum. 2006 Sep;54(9):2793-806. doi: 10.1002/art.22025. Arthritis Rheum. 2006. PMID: 16947627 Clinical Trial.
Rheumatoid arthritis: where are we now?
Smolen J, Keystone EC. Smolen J, et al. Among authors: keystone ec. Rheumatology (Oxford). 2012 Jul;51 Suppl 5:v1-2. doi: 10.1093/rheumatology/kes112. Rheumatology (Oxford). 2012. PMID: 22718921 No abstract available.
Malignant pyoderma.
Novice FM, Hacker P, Unger WP, Keystone EC. Novice FM, et al. Among authors: keystone ec. Int J Dermatol. 1987 Jan-Feb;26(1):42-4. doi: 10.1111/j.1365-4362.1987.tb04574.x. Int J Dermatol. 1987. PMID: 3557789
Intravenous golimumab in rheumatoid arthritis.
Cohen MD, Keystone EC. Cohen MD, et al. Among authors: keystone ec. Expert Rev Clin Immunol. 2014 Jul;10(7):823-30. doi: 10.1586/1744666X.2014.918847. Epub 2014 May 15. Expert Rev Clin Immunol. 2014. PMID: 24831189 Review.
Arthritis clinical trials at a crossroad.
Pope JE, Thorne JC, Haraoui BP, Karsh J, Keystone EC, Bennett L. Pope JE, et al. Among authors: keystone ec. J Rheumatol. 2015 Jan;42(1):14-7. doi: 10.3899/jrheum.140717. J Rheumatol. 2015. PMID: 25554805 No abstract available.
Therapeutic targets for rheumatoid arthritis.
Keystone EC, Haraoui B. Keystone EC, et al. J Rheumatol Suppl. 2009 Jun;82:1. doi: 10.3899/jrheum.090123. J Rheumatol Suppl. 2009. PMID: 19509323 No abstract available.
Fibrocyte activation in rheumatoid arthritis.
Galligan CL, Siminovitch KA, Keystone EC, Bykerk V, Perez OD, Fish EN. Galligan CL, et al. Among authors: keystone ec. Rheumatology (Oxford). 2010 Apr;49(4):640-51. doi: 10.1093/rheumatology/kep265. Epub 2009 Oct 25. Rheumatology (Oxford). 2010. PMID: 19858121 Free PMC article.
298 results